Brief ReportCheckpoint Inhibitors in Metastatic EGFR-Mutated Non–Small Cell Lung Cancer—A Meta-Analysis
Under an Elsevier user license
open archive
Keywords
NSCLC
EGFR mutation
Immune checkpoint inhibitors
Predictive biomarker
Cited by (0)
Disclosure: The authors declare no conflict of interest.
© 2016 International Association for the Study of Lung Cancer. Published by Elsevier Inc.